The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Lipid nanoparticles for parenteral delivery of actives
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Self-citationMuller, R. H., & Keck, C. M. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.06.007 · Cited by 819
Nanostructured lipid carriers (NLC) in cosmetic dermal products☆
MULLER, R., PETERSEN, R., HOMMOSS, A., & PARDEIKE, J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.012 · Cited by 700
Potential of solid lipid nanoparticles in brain targeting.
Kaur, I. P., Bhandari, R., Bhandari, S., & Kakkar, V. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.018 · Cited by 615
Lipid nanoparticles for improved topical application of drugs for skin diseases☆
SCHAFERKORTING, M., MEHNERT, W., & KORTING, H. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.006 · Cited by 614
Schwarz, C., Mehnert, W., Lucks, J. S., & Müller, R. H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90047-7 · Cited by 574
Self-citationPassage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)
Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Ivanov, A. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 539
Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., & Yang, C. Z. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00007-3 · Cited by 476
Drug-loaded nanoparticles : preparation methods and drug targeting issues
Allémann, É., Gurny, R., & Doelker, É. (1993) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 454
Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin
Cavalli, R., Gasco, M. R., Chetoni, P., Burgalassi, S., & Saettone, M. F. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00080-7 · Cited by 389
Manjunath, K., & Venkateswarlu, V. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.006 · Cited by 380
Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352
Wong, H. L., Bendayan, R., Rauth, A. M., Xue, H. Y., Babakhanian, K., & Wu, X. Y. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101154 · Cited by 344
Fundarò, A., Cavalli, R., Bargoni, A., Vighetto, D., Zara, G. P., & Gasco, M. R. (2000) · Pharmacological Research · doi:10.1006/phrs.2000.0695 · Cited by 317
Encapsulation of retinoids in solid lipid nanoparticles (SLN)
Volkhard Jenning, S. H. G. (2001) · Journal of Microencapsulation · doi:10.1080/02652040010000361 · Cited by 315
Doxorubicin in sterically stabilized liposomes
Lasic, D. D. (1996) · Nature · doi:10.1038/380561a0 · Cited by 308
Wong, H. L., Rauth, A. M., Bendayan, R., Manias, J. L., Ramaswamy, M., Liu, Z., Erhan, S. Z., & Wu, X. Y. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0282-x · Cited by 303
Paclitaxel nanoparticles for the potential treatment of brain tumors
Koziara, J. M., Lockman, P. R., Allen, D. D., & Mumper, R. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.006 · Cited by 299
Göppert, T. M., & Müller, R. H. (2005) · Journal of Drug Targeting · doi:10.1080/10611860500071292 · Cited by 299
Self-citationOyewumi, M. O., Yokel, R. A., Jay, M., Coakley, T., & Mumper, R. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.002 · Cited by 296
Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles☆
DATE, A., JOSHI, M., & PATRAVALE, V (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.009 · Cited by 293
Self-citationCytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant
Müller, R. H., Rühl, D., Runge, S., Schulze-Forster, K., & Mehnert, W. (1997) · Pharmaceutical Research · doi:10.1023/a:1012043315093 · Cited by 265
Self-citationBrain uptake of thiamine-coated nanoparticles
Lockman, P. R., Oyewumi, M. O., Koziara, J. M., Roder, K. E., Mumper, R. J., & Allen, D. D. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.08.006 · Cited by 259
Solid lipid nanoparticles for pulmonary delivery of insulin
Liu, J., Gong, T., Fu, H., Wang, C., Wang, X., Chen, Q., Zhang, Q., He, Q., & Zhang, Z. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.008 · Cited by 248
Lee, M.-K., Lim, S.-J., & Kim, C.-K. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.01.014 · Cited by 248
CHEN, D.-B., YANG, T.-Z., LU, W.-L., & ZHANG, Q. (2001) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.49.1444 · Cited by 243
Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.
Gill, P. S., Espina, B. M., Muggia, F., Cabriales, S., Tulpule, A., Esplin, J. A., Liebman, H. A., Forssen, E., Ross, M. E., & Levine, A. M. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.4.996 · Cited by 242
Müller, R. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04539-5 · Cited by 242
Self-citationNanotechnology for Cancer Therapy
(2006) · CRC Press eBooks · doi:10.1201/9781420006636 · Cited by 235
Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN)
Schwarz, C., & Mehnert, W. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00222-6 · Cited by 234
Advances in lipid nanodispersions for parenteral drug delivery and targeting
Constantinides, P. P., Chaubal, M. V., & Shorr, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.013 · Cited by 230
Alyautdin, R. N., Tezikov, E. B., Ramge, P., Kharkevich, D. A., Begley, D. J., & Kreuter, J. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006836 · Cited by 229
CHATTOPADHYAY, P., SHEKUNOV, B., YIM, D., CIPOLLA, D., BOYD, B., & FARR, S. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.010 · Cited by 227
Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting
Göppert, T. M., & Müller, R. H. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.06.025 · Cited by 221
Self-citationLymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles
Videira, M. A., Botelho, M. F., Santos, A. C., Gouveia, L. F., Pedroso de Lima, J. J., & Almeida, A. J. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000054933 · Cited by 213
Harivardhan Reddy, L., Sharma, R. K., Chuttani, K., Mishra, A. K., & Murthy, R. S. R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.028 · Cited by 212
Zara, G. P., Cavalli, R., Bargoni, A., Fundarò, A., Vighetto, D., & Gasco, M. R. (2002) · Journal of Drug Targeting · doi:10.1080/10611860290031868 · Cited by 207
Attama, A. A., Reichl, S., & Müller-Goymann, C. C. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.007 · Cited by 200
Chattopadhyay, N., Zastre, J., Wong, H.-L., Wu, X. Y., & Bendayan, R. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9615-2 · Cited by 194
Gupta, Y., Jain, A., & Jain, S. K. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.7.0004 · Cited by 192
Lipid Nanoparticles (SLN®, NLC®) for Cutaneous Drug Delivery:Structure, Protection and Skin Effects
Souto, E. B., Almeida, A. J., & Müller, R. H. (2007) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2007.049 · Cited by 186
Self-citationSolid Lipid Nanoparticles as Delivery Systems for Bromocriptine
Esposito, E., Fantin, M., Marti, M., Drechsler, M., Paccamiccio, L., Mariani, P., Sivieri, E., Lain, F., Menegatti, E., Morari, M., et al. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9514-y · Cited by 183
Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA
Olbrich, C., Bakowsky, U., Lehr, C.-M., Müller, R. H., & Kneuer, C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00506-5 · Cited by 181
Self-citationMiglietta, A., Cavalli, R., Bocca, C., Gabriel, L., & Rosa Gasco, M. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00562-7 · Cited by 180
Wang, J.-X., Sun, X., & Zhang, Z.-R. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00083-8 · Cited by 179
Wong, H. L., Bendayan, R., Rauth, A. M., & Wu, X. Y. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20100 · Cited by 178
Solid lipid nanoparticles (SLN) for controlled drug delivery
Müller, R. H., Freitas, C., zur Mühlen, A., & Mehnert, W. (1996) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)86243-4 · Cited by 174
Self-citationInvited Review: Development of Fat Emulsions
WRETLIND, A. (1981) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607181005003230 · Cited by 172
Nanoparticulate Drug Delivery Systems
(2007) · CRC Press eBooks · doi:10.1201/9781420008449 · Cited by 171
Joshi, M., Pathak, S., Sharma, S., & Patravale, V. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.032 · Cited by 168
Self-citationSerpe, L., Catalano, M. G., Cavalli, R., Ugazio, E., Bosco, O., Canaparo, R., Muntoni, E., Frairia, R., Gasco, M. R., Eandi, M., et al. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.026 · Cited by 165
In-vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors
Koziara, J. M., Whisman, T. R., Tseng, M. T., & Mumper, R. J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.001 · Cited by 158
Tabatt, K., Sameti, M., Olbrich, C., Müller, R. H., & Lehr, C. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.10.015 · Cited by 152
Self-citationSchöler, N., Hahn, H. H., Müller, R. H., & Liesenfeld, O. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00882-1 · Cited by 149
Self-citationSolid Lipid Nanoparticles in Lymph and Plasma After Duodenal Administration to Rats
Bargoni, A., Cavalli, R., Caputo, O., Fundaro', A., Gasco, M. R., & Zara, G. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011975120776 · Cited by 148
Protein adsorption patterns on poloxamer- and poloxamine-stabilized solid lipid nanoparticles (SLN)
Göppert, T. M., & MULLER, R. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.02.006 · Cited by 145
Schöler, N., Olbrich, C., Tabatt, K., Müller, R. H., Hahn, H. H., & Liesenfeld, O. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00660-3 · Cited by 145
Self-citationZara, G. P., Bargoni, A., Cavalli, R., Fundaro', A., Vighetto, D., & Gasco, M. R. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10129 · Cited by 143
Schöler, N., Krause, K., Kayser, O., Müller, R. H., Borner, K., Hahn, H. H., & Liesenfeld, O. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1771-1779.2001 · Cited by 140
Self-citationReddy, L. H., Sharma, R. K., Chuttani, K., Mishra, A. K., & Murthy, R. R. (2004) · The AAPS Journal · doi:10.1208/aapsj060323 · Cited by 135
Ye, J., Wang, Q., Zhou, X., & Zhang, N. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.10.014 · Cited by 134
Lim, S., Lee, M., & Kim, C. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.032 · Cited by 128
Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes
Tabatt, K., Kneuer, C., Sameti, M., Olbrich, C., Müller, R. H., Lehr, C., & Bakowsky, U. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.029 · Cited by 123
Self-citationLu, B., Xiong, S.-B., Yang, H., et al. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.01.001 · Cited by 120
Gessner, A., Olbrich, C., Schröder, W., Kayser, O., & Müller, R. H. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00639-6 · Cited by 118
Self-citationInfluence of different parameters on reconstitution of lyophilized SLN
Zimmermann, E., Müller, R. H., & Mäder, K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00424-x · Cited by 118
Self-citationSolid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands
Pedersen, N. M., Hansen, S. H., Heydenreich, A. V., Kristensen, H. G., & Poulsen, H. S. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.09.003 · Cited by 117
Solid lipid nanoparticles of temozolomide: Potential reduction of cardial and nephric toxicity
Huang, G., Zhang, N., Bi, X., & Dou, M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.013 · Cited by 114
Sznitowska, M., Gajewska, M., Janicki, S., Radwanska, A., & Lukowski, G. (2001) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00157-6 · Cited by 113
Drug Delivery to the Brain – Realization by Novel Drug Carriers
Müller, R. H., & Keck, C. M. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2004.078 · Cited by 113
Self-citationMüller, R. H. (1991) · Medical Entomology and Zoology · Cited by 107
Self-citationDressman, J. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90174-p · Cited by 105
Manjunath, K., & Venkateswarlu, V. (2006) · Journal of drug targeting · doi:10.1080/10611860600888850 · Cited by 103
In VitroandIn VivoStudy of Solid Lipid Nanoparticles Loaded with Superparamagnetic Iron Oxide
Peira, E., Marzola, P., Podio, V., Aime, S., Sbarbati, A., & Gasco, M. R. (2003) · Journal of drug targeting · doi:10.1080/1061186031000086108 · Cited by 102
Bargoni, A., Cavalli, R., Zara, G. P., Fundaro', A., Caputo, O., & Gasco, M. R. (2001) · Pharmacological Research · doi:10.1006/phrs.2001.0813 · Cited by 101
Müller, R. H., Maassen, S., Schwarz, C., & Mehnert, W. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)01653-2 · Cited by 100
Self-citationHeydenreich, A. V. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00688-9 · Cited by 98
Olbrich, C., Gessner, A., Schröder, W., Kayser, O., & Müller, R. H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.024 · Cited by 95
Self-citationLung-targeting delivery of dexamethasone acetate loaded solid lipid nanoparticles
Xiang, Q., Wang, M.-T., Chen, F., Gong, T., Jian, Y.-L., Zhang, Z., & Huang, Y. (2007) · Archives of Pharmacal Research · doi:10.1007/bf02980228 · Cited by 88
Weyhers, H., Ehlers, S., Hahn, H. H., et al. (2006) · PubMed · Cited by 73
Bondì, M. L., Craparo, E. F., Giammona, G., Cervello, M., Azzolina, A., Diana, P., Martorana, A., & Cirrincione, G. (2007) · Drug Delivery · doi:10.1080/10717540600739914 · Cited by 73
Burgess, D. J., Duffy, E. P., Etzler, F. M., & Hickey, A. J. (2004) · The AAPS Journal · doi:10.1208/aapsj060320 · Cited by 72
Eckart, J., Adolph, M., Mühlen, U. V. D., & Naab, V. (1980) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860718000400405 · Cited by 65
Solid lipid nanoparticles as drug carriers
Heiati, H., TAWASHI, R., & Phillips, N. C. (1998) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00236-1 · Cited by 63
Coating of cationized protein on engineered nanoparticles results in enhanced immune responses
Cui, Z., & Mumper, R. J. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00079-0 · Cited by 62
Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery
Bondì, M. L., Azzolina, A., Craparo, E. F., Lampiasi, N., Capuano, G., Giammona, G., & Cervello, M. (2007) · Journal of drug targeting · doi:10.1080/10611860701324698 · Cited by 61
Dianzani, C., Cavalli, R., Zara, G. P., Gallicchio, M., Lombardi, G., Gasco, M. R., Panzanelli, P., & Fantozzi, R. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706761 · Cited by 60
Folate-Linked Lipid-Based Nanoparticle for Targeted Gene Delivery
Hattori, Y., & Maitani, Y. (2005) · Current Drug Delivery · doi:10.2174/1567201054368002 · Cited by 60
Influence of surfactants on the physical stability of solid lipid nanoparticle (SLN) formulations.
Üner, M., Wissing, S. A., Yener, G., & Müller, R. H. (2004) · PubMed · Cited by 55
Self-citationNanoparticulate Drug-Delivery Systems
Thassu, D., Pathak, Y. V., & Deleers, M. (2007) · Drugs and the pharmaceutical sciences · doi:10.1201/9781420008449.ch1 · Cited by 55
Chen, D., Yang, T.-Z., Lü, W.-L., & Zhang, Q. (2002) · PubMed · Cited by 52
Lymphatic uptake of lipid nanoparticles following endotracheal administration
Videira, M., Gano, L., dos Santos, C. P., Neves, M., & Almeida, A. J. (2006) · Journal of Microencapsulation · doi:10.1080/02652040600788221 · Cited by 49
Olbrich, C., Schöler, N., Tabatt, K., et al. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023754 · Cited by 44
Podio, V., Zara, G. P., Carazzone, M., et al. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001774976 · Cited by 38
Olbrich, C., Müller, R. H., Tabatt, K., Kayser, O., Schulze, C., & Schade, R. (2002) · Alternatives to Laboratory Animals · doi:10.1177/026119290203000407 · Cited by 37
Self-citationSchöler, N., Zimmermann, E., Katzfey, U., et al. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00430-5 · Cited by 35
Schöler, E. Z. N. (2000) · Journal of Microencapsulation · doi:10.1080/026520400417685 · Cited by 24
Göppert, T. M., & Müller, R. H. (2004) · Electrophoresis · doi:10.1002/elps.200305690 · Cited by 20
Self-citation
Cited by
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K., Smith, B., Lee, J.-H., Yavlovich, A., Heldman, E., & Blumenthal, R. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,069
Mohammadi-Samani, S., & Ghasemiyeh, P. (2018) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.235156 · Cited by 970
Minireview: Nanoparticles and the Immune System
Zolnik, B. S., González-Fernández, A., Sadrieh, N., & Dobrovolskaia, M. A. (2010) · Endocrinology · doi:10.1210/en.2009-1082 · Cited by 914
Polysaccharide-based aerogels—Promising biodegradable carriers for drug delivery systems
García-González, C. A., Alnaief, M., & Smirnova, I. (2011) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.06.066 · Cited by 725
Metadata
- Authors
- Joshi, M. D., & Müller, R. H.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 71
- Issue
- 2
- Pages
- 161-172
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2013997434
- Cited by
- 433
- References
- 98
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.